At a glance
Retinal vein occlusion and the risk of acute myocardial infarction
Hu et al used a nationwide (Taiwan) population-based dataset to investigate the relationship between retinal vein occlusion (RVO) and subsequent acute myocardial infarction (AMI). The study cohort consisted of 591 ambulatory care patients with RVO (2000–2003). Each patient was individually tracked for 3 years. Although, RVO patients had a significantly higher rate of AMI (1.9% vs 0.8%) than controls (p = 0.03), after adjusting for gender, age and comorbid medical disorders, there was no significant difference between the study group and controls. The authors conclude that RVO did not independently increase the risk of AMI.
See pages 717
Triple therapy for neovascular AMD
Yip et al evaluated the efficacy and safety of triple therapy consisting of a single-session photodynamic therapy (PDT, standard protocol), intravitreal bevacizumab (IVB, 1.25 mg) and intravitreal triamcinolone (IVTA, 4 mg) for treatment of neovascular AMD in 36 eyes of 33 consecutive patients with subfoveal CNV with mean follow-up of 14.7 (6.9–19.2) months. At 6 …